state_legiscan_drain · NJ
Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.
May 14, 2026
Summary
If enacted, this bill would require health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders in New Jersey. The mandate applies to health insurers and the state Medicaid program, ensuring coverage for FDA-approved diagnostic tests and treatments that slow cognitive decline. This would expand access for patients and potentially reduce long-term care costs.
AI-generated summary · Jul 10, 2026. Verify with your compliance counsel before acting.
How this was generated
We record the exact prompt, model, and output for every AI response so it can be audited for accuracy.
Source: https://www.njleg.state.nj.us/bill-search/2026/A5062
Common questions
- What does "Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders." cover?
- If enacted, this bill would require health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and…
- When was it published?
- It was published on May 14, 2026.